Safety and Immunogenicity of a Group B Streptococcus Vaccine in Healthy Women
Clinical trial NCT01150123 · COMPLETED
Trial details
- NCT number
- NCT01150123
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-11-01
- Enrollment
- 678
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.